Quercetin - Drug Monograph

Comprehensive information about Quercetin including mechanism, indications, dosing, and safety information.

Introduction

Quercetin is a naturally occurring flavonoid compound found in various fruits, vegetables, and grains. As a dietary supplement, it has gained significant attention for its potential health benefits and pharmacological properties. While not approved as a pharmaceutical drug by regulatory agencies, quercetin is widely available as a nutritional supplement and has been extensively studied for its antioxidant, anti-inflammatory, and potential therapeutic effects.

Mechanism of Action

Quercetin exerts its effects through multiple mechanisms:

  • Antioxidant activity: Scavenges free radicals and reactive oxygen species through its phenolic structure
  • Anti-inflammatory effects: Modulates inflammatory pathways by inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) enzymes
  • Enzyme modulation: Inhibits various enzymes including xanthine oxidase, protein kinase C, and phospholipase A2
  • Cell signaling modulation: Affects numerous intracellular signaling pathways including NF-κB and MAPK pathways
  • Histamine inhibition: Acts as a mast cell stabilizer and inhibits histamine release
  • Metal chelation: Binds to metal ions, potentially reducing oxidative stress

Indications

Note: Quercetin is not FDA-approved for any medical indications. The following uses are based on preliminary research and traditional use:
  • Dietary supplement for general antioxidant support
  • Potential adjunctive support for inflammatory conditions
  • Investigationally studied for cardiovascular health support
  • Research interest in metabolic syndrome and allergy management
  • Exploration in cancer prevention and supportive care contexts

Dosage and Administration

Typical supplemental doses: 500-1000 mg daily, divided into 2-3 doses Higher investigational doses: Up to 2000 mg daily under medical supervision Administration: Preferably with meals to enhance absorption Special populations:
  • Elderly: No specific dosage adjustments established
  • Renal impairment: Use with caution due to limited safety data
  • Hepatic impairment: Use with caution due to limited safety data
  • Pregnancy and lactation: Not recommended due to insufficient safety data

Pharmacokinetics

Absorption: Poor and variable bioavailability (approximately 2-20%) due to low water solubility and extensive metabolism Distribution: Widely distributed throughout tissues; crosses the blood-brain barrier Metabolism: Extensive first-pass metabolism via phase II enzymes (glucuronidation, sulfation, methylation) Elimination: Primarily renal excretion of metabolites; half-life approximately 3.5 hours Factors affecting bioavailability: Concomitant food intake, formulation (liposomal or phospholipid complexes may enhance absorption), and individual variation in gut microbiota

Contraindications

  • Known hypersensitivity to quercetin or related flavonoids
  • Pregnancy and breastfeeding (due to insufficient safety data)
  • Severe renal or hepatic impairment (theoretical risk due to limited elimination data)

Warnings and Precautions

  • May interact with numerous medications (see Drug Interactions section)
  • Theoretical risk of nephrotoxicity at high doses
  • Potential for allergic reactions in sensitive individuals
  • Quality control concerns with dietary supplements (variability in potency and purity)
  • Long-term safety data limited beyond 12 weeks of continuous use

Drug Interactions

Cytochrome P450 interactions:
  • Inhibits CYP3A4, CYP2C9, and CYP2D6 (may increase levels of substrates)
  • Potential interaction with drugs metabolized by these enzymes
Transport protein interactions:
  • Inhibits P-glycoprotein (may affect digoxin, cyclosporine, and other P-gp substrates)
Specific medication interactions:
  • Anticoagulants: Theoretical increased bleeding risk
  • Chemotherapy drugs: May alter efficacy (consult oncologist)
  • Antibiotics: May affect fluoroquinolone absorption
  • Immunosuppressants: Potential interaction with cyclosporine and tacrolimus
Nutrient interactions:
  • Vitamin C: May enhance absorption and effects
  • Bromelain: Often combined to potentially enhance absorption

Adverse Effects

Common effects (typically mild and dose-related):
  • Headache
  • Gastrointestinal discomfort (nausea, heartburn)
  • Peripheral tingling sensation
Rare effects:
  • Allergic reactions (rash, urticaria)
  • Renal toxicity (with very high doses)
  • Hepatotoxicity (case reports with high doses)
Theoretical risks:
  • Pro-oxidant effects at very high concentrations
  • Hormonal effects due to weak estrogenic activity

Monitoring Parameters

  • Renal function (BUN, creatinine) with long-term high-dose use
  • Liver function tests with prolonged high-dose supplementation
  • Clinical assessment for efficacy and adverse effects
  • Medication levels for drugs with narrow therapeutic indices
  • Bleeding parameters if used with anticoagulants

Patient Education

  • Quercetin is a dietary supplement, not an FDA-approved medication
  • Inform healthcare providers about all supplement use
  • Purchase from reputable manufacturers that provide third-party testing
  • Be aware of potential interactions with prescription medications
  • Discontinue use 2 weeks before elective surgery due to potential bleeding risk
  • Report any unusual symptoms or side effects to healthcare provider
  • Understand that evidence for many claimed benefits is preliminary
  • Do not use as replacement for prescribed medications without medical consultation

References

1. Boots AW, et al. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008;585(2-3):325-337. 2. Li Y, et al. Quercetin, inflammation and immunity. Nutrients. 2016;8(3):167. 3. Andres S, et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 2018;62(1):1700447. 4. D'Andrea G. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia. 2015;106:256-271. 5. National Institutes of Health Office of Dietary Supplements. Quercetin Fact Sheet for Health Professionals. 6. European Food Safety Authority. Scientific Opinion on the safety of quercetin. EFSA Journal. 2011;9(4):2067. 7. Kelly GS. Quercetin. Altern Med Rev. 2011;16(2):172-194. 8. ClinicalTrials.gov. Search results for quercetin clinical trials.

This monograph is for educational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new supplement regimen.

Medical Disclaimer

The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

The content on MedQuizzify is designed to support, not replace, the relationship that exists between a patient and their healthcare provider. If you have a medical emergency, please call your doctor or emergency services immediately.

How to Cite This Article

admin. Quercetin - Drug Monograph. MedQuizzify [Internet]. 2025 Sep 10 [cited 2025 Sep 10]. Available from: http://medquizzify.pharmacologymentor.com/blog/drug-monograph-quercetin

Enjoyed this post?

Subscribe to our newsletter and get more educational insights, quiz tips, and learning strategies delivered weekly to your inbox.